1. Home
  2. ESPR vs VSTA Comparison

ESPR vs VSTA Comparison

Compare ESPR & VSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • VSTA
  • Stock Information
  • Founded
  • ESPR 2008
  • VSTA 1966
  • Country
  • ESPR United States
  • VSTA Brazil
  • Employees
  • ESPR N/A
  • VSTA N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • VSTA Other Consumer Services
  • Sector
  • ESPR Health Care
  • VSTA Real Estate
  • Exchange
  • ESPR Nasdaq
  • VSTA Nasdaq
  • Market Cap
  • ESPR 305.0M
  • VSTA 357.6M
  • IPO Year
  • ESPR 2013
  • VSTA 2020
  • Fundamental
  • Price
  • ESPR $0.95
  • VSTA $4.87
  • Analyst Decision
  • ESPR Buy
  • VSTA Sell
  • Analyst Count
  • ESPR 7
  • VSTA 2
  • Target Price
  • ESPR $6.07
  • VSTA $3.00
  • AVG Volume (30 Days)
  • ESPR 5.5M
  • VSTA 73.2K
  • Earning Date
  • ESPR 05-06-2025
  • VSTA 05-07-2025
  • Dividend Yield
  • ESPR N/A
  • VSTA N/A
  • EPS Growth
  • ESPR N/A
  • VSTA N/A
  • EPS
  • ESPR N/A
  • VSTA 0.98
  • Revenue
  • ESPR $332,314,000.00
  • VSTA $270,690,068.00
  • Revenue This Year
  • ESPR $5.17
  • VSTA $12.95
  • Revenue Next Year
  • ESPR N/A
  • VSTA $11.85
  • P/E Ratio
  • ESPR N/A
  • VSTA $4.93
  • Revenue Growth
  • ESPR 185.66
  • VSTA 12.64
  • 52 Week Low
  • ESPR $0.93
  • VSTA $1.60
  • 52 Week High
  • ESPR $3.94
  • VSTA $5.49
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 22.73
  • VSTA 64.30
  • Support Level
  • ESPR $0.93
  • VSTA $4.60
  • Resistance Level
  • ESPR $1.06
  • VSTA $5.49
  • Average True Range (ATR)
  • ESPR 0.09
  • VSTA 0.51
  • MACD
  • ESPR -0.02
  • VSTA 0.02
  • Stochastic Oscillator
  • ESPR 3.57
  • VSTA 68.11

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About VSTA Vasta Platform Limited

Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.

Share on Social Networks: